Cargando…
Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy
Pancreatic cancer is one of the most lethal tumor types worldwide and an effective therapy is still elusive. Targeted therapy focused against a specific alteration is by definition unable to attack broad pathway signaling modification. Tumor heterogeneity will render targeted therapies ineffective b...
Autores principales: | Werner, Kristin, Lademann, Franziska, Thepkaysone, May-Linn, Jahnke, Beatrix, Aust, Daniela E., Kahlert, Christoph, Weber, Georg, Weitz, Jürgen, Grützmann, Robert, Pilarsky, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826184/ https://www.ncbi.nlm.nih.gov/pubmed/26716649 http://dx.doi.org/10.18632/oncotarget.6766 |
Ejemplares similares
-
The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation
por: Jahny, Elisabeth, et al.
Publicado: (2017) -
Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
por: Rückert, Felix, et al.
Publicado: (2010) -
Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014) -
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
por: Wiesmueller, Felix, et al.
Publicado: (2019) -
Detection of COPB2 as a KRAS synthetic lethal partner through integration of functional genomics screens
por: Christodoulou, Eleni G., et al.
Publicado: (2017)